GA
GILD icon

Geneva Advisors’s Gilead Sciences GILD Stock Holding History

Geneva Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3.49M Sell
49,247
-542
-1% -$36.1K 0.06% 146
2017
Q1 		$3.38M Sell
49,789
-70,468
-59% -$4.96M 0.06% 152
2016
Q4 		$8.61M Sell
120,257
-780
-0.6% -$58K 0.17% 94
2016
Q3 		$9.58M Sell
121,037
-10,123
-8% -$822K 0.18% 93
2016
Q2 		$10.9M Sell
131,160
-4,674
-3% -$415K 0.22% 83
2016
Q1 		$12.5M Sell
135,834
-434,124
-76% -$39.1M 0.25% 78
2015
Q4 		$57.7M Buy
569,958
+7,500
+1% +$780K 1.11% 30
2015
Q3 		$55.2M Buy
562,458
+245,862
+78% +$27.3M 1.11% 30
2015
Q2 		$37.1M Buy
316,596
+20,090
+7% +$2.2M 0.66% 53
2015
Q1 		$29.1M Sell
296,506
-158,531
-35% -$16.1M 0.53% 63
2014
Q4 		$42.9M Sell
455,037
-20,331
-4% -$2.1M 0.8% 47
2014
Q3 		$50.6M Sell
475,368
-186,727
-28% -$18.3M 0.95% 39
2014
Q2 		$54.9M Sell
662,095
-417,964
-39% -$32.5M 1% 38
2014
Q1 		$76.5M Sell
1,080,059
-260,481
-19% -$20.4M 1.41% 15
2013
Q4 		$101M Buy
1,340,540
+21,702
+2% +$1.51M 1.86% 10
2013
Q3 		$82.9M Buy
1,318,838
+3,631
+0.3% +$217K 1.72% 11
2013
Q2 		$67.4M Buy
+1,315,207
New +$68.6M 1.57% 20

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneva Advisors's GILD Position: Q2 2017 in Review

Geneva Advisors reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2017, selling an estimated $36.1K and leaving 49,247 shares worth $3.49M. The position accounts for 0.06% of the portfolio, ranked #146.

Geneva Advisors first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $101M in Q4 2013. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Geneva Advisors held 49,247 shares of Gilead Sciences worth $3.49M as of Q2 2017.
  • Geneva Advisors sold 542 Gilead Sciences shares in Q2 2017, an estimated $36.1K.
  • Gilead Sciences made up 0.06% of Geneva Advisors's portfolio in Q2 2017, its #146 holding.
  • Geneva Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Gilead Sciences position peaked at $101M in Q4 2013.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.